BIOA 8-K 2026-11-05

BioAge Labs, Inc. (BIOA) 8-K dated 2026-11-05 — accession 0001193125-26-450008.

BioAge Labs, Inc. (BIOA) is a drug manufacturers - specialty & generic company listed on US.

BioAge Labs, Inc. filed a 8-K on 2026-11-05. Accession 0001193125-26-450008.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.

Not investment advice. The BIOA SEC hub lists recent forms. The stock page is the research view.